Carmustine and malignant neoplasm progression Patient Reports February 11, 2012

Carmustine Side Effects Report #4611389-2
Carmustine side effect was reported by a Health Professional from on Mar 15, 2005. Male patient, weighting 192.5 lb, was diagnosed with glioblastoma multiforme and was treated with Carmustine. After drug was administered, patient experienced the following side effects: brain herniation, brain oedema, dyspnoea, glioblastoma multiforme, malignant neoplasm progression, pneumonia , pneumonia aspiration. Carmustine dosage: 206 MG IV ONCE Q 6 WEEKS. During the same period patient was treated with TOPOTECAN, DILANTIN, LEXAPRO, DECADRON, ZANTAC, HYDROCODONE BITARTRATE, PHENERGAN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Carmustine Side Effects Report #4611393-4
Carmustine side effect was reported by a Health Professional from on Mar 15, 2005. Male patient, weighting 172.8 lb, was diagnosed with glioblastoma multiforme and was treated with Carmustine. After drug was administered, patient experienced the following side effects: cholelithiasis, emphysematous cholecystitis, malignant neoplasm progression. Carmustine dosage: 200MG IV ONCE Q 6 WEEKS. During the same period patient was treated with TOPOTECAN, LIPITOR, HYDROCHLOROTHIAZIDE, COREG, CALTRATE, DECADRON, ZANTAC. Patient was hospitalized. Patient recovered.

Carmustine Side Effects Report #4623127-8
Carmustine side effect was reported by a Health Professional from on Mar 28, 2005. Female patient, weighting 203.3 lb, was diagnosed with anaplastic astrocytoma and was treated with Carmustine. After drug was administered, patient experienced the following side effects: body temperature increased, convulsion, headache , malignant neoplasm progression. Carmustine dosage: 209 MG IV ONCE Q 6 WEEKS. During the same period patient was treated with TOPOTECAN, COLACE, DILANTIN, DECADRON, PROTONIX, COUMIDIN. Patient was hospitalized. Patient recovered.